Eileen Novins: The Marfan Foundation Supports The Work of The WHF
Eileen Novins, Chief Global Business Development Officer at The Marfan Foundation, shared Jagat Narula’s post on LinkedIn:
“Thanks to the World Heart Federation for putting the spotlight on neglected cardiovascular diseases, including aortopathies. In many cases, these are not rare conditions, but they are neglected. The Marfan Foundation supports the work of the WHF and continues to align with the critical work they are doing internationally.”
Jagat Narula President at World Heart Federation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The Lancet Summit, adding:
“A child should not die from a heart condition simply because of the zip code or country of their birth. Yet for millions of children, adolescents, and young adults around the world, that remains the reality.
I am pleased to share our declaration in The Lancet, on behalf of the World Heart Federation, Cardiomyopathy Network, and Marfan Foundation: ‘2026: The Year of Neglected Cardiac Diseases.’
Cardiovascular medicine has witnessed extraordinary progress. We can diagnose disease earlier, and intervene more effectively. Yet the benefits of these advances remain profoundly unequal.
Today, an estimated 100 million people are living with neglected cardiac diseases, with a disproportionate burden among children and young adults and in low- and middle-income countries. Despite their enormous human toll, these conditions remain insufficiently represented on national and global health agendas.
Perhaps nowhere is this inequity more striking than in congenital heart disease. A child born with CHD in a well-resourced health system can often expect timely diagnosis, corrective intervention, and the prospect of a long and productive life. A child born with the same condition elsewhere may never receive a diagnosis, much less the specialist care or surgery that could save their life.
The disease is the same. The opportunity to survive is not.
This is why the World Heart Federation has designated 2026 as the Year of Neglected Cardiac Diseases, focusing global attention on four major areas: rheumatic heart disease, Chagas disease, congenital heart disease, and inherited cardiomyopathies and aortopathies.
These diseases differ profoundly in their biology, geography, and clinical manifestations, but they share one disturbing reality: much of their burden persists not because science lacks answers, but because knowledge, proven interventions, and effective care have not reached those who need them most.
In our Lancet declaration, we call for stronger political commitment, sustained investment, more resilient health systems, earlier diagnosis, expanded access to specialist care, and implementation of interventions we already know can save lives.
The challenge before us is therefore not simply one of discovery. It is one of implementation and collective responsibility. The knowledge exists. The tools exist. The opportunity exists.
What we need now is the collective resolve to ensure that geography, income, or circumstance no longer determines who receives life-saving cardiovascular care and who does not.
I hope you will join us in advancing this mission.
My sincere thanks to all authors for joining together around this important cause. It is time to bring neglected cardiac diseases out of the shadows and place them firmly at the center of the global cardiovascular agenda.”
Title: The Year of Neglected Cardiac Diseases
Authors: Jagat Narulaa, Gregory Rothb, Dorairaj Prabhakarana, Andrea Beatonc, Daniel Piñeiroa, Eduardo Bossonef, Michael Weamerf , Yunshu Wanga, Borjana Pervana, Kim A Eagleh, Perry Elliottk, Bente Mikkelsenm, George A Mensahn, R Krishna Kumarc,

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 24, 2026, 15:15Jim Hoffman: Could Targeting NETosis Reduce Long-Term Risk After STEMI?
-
Aug 24, 2026, 14:58Danny Hsu: Rethinking Bleeding Risk in Patients on Anticoagulation
-
Aug 24, 2026, 14:18The Way to a Safer Workplace for People With Bleeding Disorders – EHC
-
Aug 24, 2026, 14:09Stuart Andrew: NHS Blood and Transplant Strengthening the Blood Supply
-
Aug 24, 2026, 14:05Edward Lee Carter: Anticoagulation Stewardship is Moving From Recommendation to Measurement
-
Aug 24, 2026, 13:58Meera Chitlur: Transforming Care for Heavy Menstrual Bleeding at Children’s Hospital of Michigan
-
Aug 24, 2026, 13:49Heghine Khachatryan: Prepartum Acquired Hemophilia A and the Challenge of Maternal and Neonatal Bleeding
-
Aug 24, 2026, 13:44Neeraj Songara: Therapeutic Plasma Exchange in Severe Guillain–Barré Syndrome
-
Aug 24, 2026, 13:42Pall T. Onundarson: The Role of Measuring Treatment Effect in Optimizing DOAC and Warfarin Therapy